Related Publications
- Analysis of the effect of primaquine dose on efficacy, safety, and tolerability in patients with Plasmodium vivax malaria in Ethiopia: a systematic review and individual patient data meta-analysis
- Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysis
- Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
- Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis
- Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial
- Effectiveness and Safety of High Dose Primaquine and Tafenoquine in Plasmodium vivax Patients (EFFORT) – A Multi-Centre, Open Label, Superiority Randomised Controlled Trial
- Evidence Based Optimal Dosing of Intravenous Artesunate in Children with Severe Falciparum Malaria
- How to use learning curves to evaluate the sample size for malaria prediction models developed using machine learning algorithms
- Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis
- Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial
- Quantification of parasite clearance in Plasmodium knowlesi infections
- Reducing the risk of Plasmodium vivax after falciparum infections in co-endemic areas – a radomised controlled trial
- Short-Course Low-Dose Primaquine for Radical Cure in G6PD-Normal Patients in the Pre-Elimination Context of Nepal
- The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial
- The role of the spleen in red blood cell loss caused by malaria: A mathematical model
Dr Megha Rajasekhar is a biostatistician working at the Centre for Epidemiology and Biostatistics within the School of Population and Global Health at the University of Melbourne.